CVE-2023-26097: Telindus Apsal
Medium severity, CVSS 5.5. EPSS: 0.2% chance of exploitation in the next 30 days.
An issue was discovered in Telindus Apsal 3.14.2022.235 b. Unauthorized actions that could modify the application behaviour may not be blocked.
Affected products
- Telindus Apsal: version 3.14.2022.235_b only
Published 2023-04-24. Last modified 2026-06-17.